Skip to content
Options Trading Report

Options Trading Report

Primary Menu
  • Home
  • Business
  • Economy
  • Top News
  • Newsletters
  • Home
  • 2026
  • May
  • Who is Behind Nvidia’s Trillion-Dollar Robot
  • Newsletters

Who is Behind Nvidia’s Trillion-Dollar Robot

Editor May 24, 2026 5 minutes read
65ecb959-3d22-4513-b6ef-ae2587fcfbd4

May 24, 2026

Who is Behind Nvidia’s Trillion-Dollar Robot

Featured: Palo Alto Networks – What the 44% Run Is Actually Telling You


Sponsored

Dear Reader,

Robots are standing on the edge of history.

No one would know this better than Nvidia’s Jensen Huang.

In Las Vegas, the CEO of the world’s most valuable company did more than just talk.

He laid out their vision for building the world’s first trillion-dollar robot.

I fully believe Huang’s plan will be ready to go mainstream soon.

All thanks to a special announcement by President Trump that I think could come any day now.

But for that to become a reality …

Nvidia needs the help of one $7 company.

You see, there is one thing Nvidia can’t do …

And they need the technology of this virtually unknown $7 stock to finish the job.

During our Memorial Day Savings Event…

We’re giving you insider access to ALL of Weiss Ratings’ Disruptors and Dominators benefits …

Full of executive-quality research on the exciting world of tech investing … just like these robots …

For just $19.

That’s a savings of 85%!

This is a limited-time opportunity that doesn’t happen often.

To see how you can benefit, click here now.

Eliza Lasky
Weiss Ratings

P.S. Michael Robinson has been at the forefront of the technology market for over 40 years.

Spotting some profitable trends in tech … well ahead of Wall Street.

Like when he called Nvidia at a mere 80 cents a share.

Or Bitcoin when it was trading for just $300.

Throughout his illustrious career …

Michael has given his followers almost 150 different chances to register triple-digit gains.

Including nearly 20 different chances to score gains of 1,000% or more.

Now he’s identified his next potential winner.

Click here to find out more.





FEATURED

Palo Alto Networks: What the 44% Run Is Actually Telling You

On March 27, Nikesh Arora bought 68,085 shares of his own company at $146.87 — roughly $10 million out of pocket, his first open-market purchase in years. That’s the part worth paying attention to.

The context matters here. A Fortune report in mid-March had flagged Anthropic’s “Mythos” AI model as a potential threat to traditional security vendors, and PANW dropped roughly 6% on the fear. Arora didn’t issue a statement. He bought stock. That distinction tells you something about where management thinks the business is heading.

Since that purchase, shares have run nearly 44% to an all-time high of $261.41 on May 22.


Analyst Price Targets

  • Wells Fargo – Overweight | PT: $285
  • Oppenheimer – Outperform | PT: $275 (raised from $245)
  • Truist Securities – Buy | PT: $275 (raised from $200)
  • Stifel Nicolaus – Buy | PT: $275 (raised from $185)
  • Rosenblatt Securities – Buy | PT: $275 (raised from $225)
  • BMO Capital Markets – Outperform | PT: $270
  • Morgan Stanley – Overweight | PT: $265 (raised from $223)
  • Jefferies – Buy | PT: $265 (raised from $215)
  • RBC Capital – Outperform | PT: $255 (raised from $220)
  • Barclays – Overweight | PT: $220 (raised from $200)

The Q2 numbers were solid. Revenue came in at $2.59B against a $2.58B estimate, up 15% year over year. Non-GAAP EPS hit $1.03 vs. $0.94 expected. GAAP net income jumped 62% to $432M. NGS ARR — the number that actually tracks platform adoption — grew 33% to $6.33B. Remaining performance obligations hit $16.0B, up 23%. Adjusted free cash flow over the trailing twelve months: $3.75B. The full-year revenue guide was raised to $11.28B–$11.31B.

The one number that caused the initial 7% drop after hours on February 17 was Q3 EPS guidance: $0.78–$0.80 against a $0.92 consensus estimate. Worth understanding why that gap exists. The CyberArk and Chronosphere acquisitions increased share count significantly — the EPS miss is largely a dilution artifact, not an operating deterioration. Q3 revenue is guided at $2.941B–$2.945B, which is 28–29% growth. That’s the actual business signal.


Sponsored


A major change to U.S. bank accounts could arrive in months.

It may allow closer tracking of your transactions.

See the 4 steps to safeguard your savings

The $25 billion CyberArk acquisition closed February 11. It added identity as a fourth core domain alongside Strata, Prisma, and Cortex. Then on May 12, PANW launched Idira — a next-generation identity platform designed to manage human, machine, and agentic identities under one architecture. Machine and AI identities now outnumber human identities 109 to 1 inside the enterprise. That’s not a niche problem. That’s the attack surface of the next decade, and PANW just staked a position at the center of it.

Slight tangent, but it matters: Palo Alto’s Unit 42 threat intelligence team has been warning enterprises about a narrow three-to-five month window to shore up defenses before AI-powered exploits accelerate meaningfully. Whether that timeline proves accurate or not, that kind of warning from a credible source tends to move security budgets. PANW is the company most positioned to absorb that spending.

What to watch on June 2: organic NGS ARR growth ex-acquisitions (the guided $7.94B–$7.96B includes $1.47B from M&A), any early Idira cross-sell data from existing CyberArk customers, and how management frames the path to the 40% free cash flow margin target by FY2028. The EPS bar is low. Clearing it isn’t the question.


The question is whether the organic growth rate — stripped of acquisition math — is holding. That’s what justifies the valuation at all-time highs. Everything else is already in the stock.


For informational purposes only.

Post navigation

Previous: The Factory Floor Is Being Rewritten in Code
Next: Elon “xPhone” Incoming?

Related Stories

229d6af6-172c-47fd-a5ac-fe6670a2b3d3
  • Newsletters

AstraZeneca’s Kidney Readout. The Real Question Is What Options Didn’t Do.

Editor October 22, 2026
121d2608-2202-4aa0-87db-b8015f5eda99
  • Newsletters

5 seconds

Editor October 22, 2026
88d21e7e-9da3-4f52-8531-5b95c067e736
  • Newsletters

[Report] The 11-Hour Options Guide for Beginners – Trade and Ticker Included

Editor October 22, 2026

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Want More Market News?
Add your email address below to get up to date market news and more!
By submitting your email address, you'll receive a free subscription to Options Trading Report newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.

Recent Posts

  • The KOSPI’s 3.52% Drop Is Now Inside the Bank of Korea
  • AstraZeneca’s Kidney Readout. The Real Question Is What Options Didn’t Do.
  • 5 seconds
  • Lam Research’s Perfect Quarter Wasn’t Enough. That’s the Problem.
  • [Report] The 11-Hour Options Guide for Beginners – Trade and Ticker Included
  • Linde’s Hydrogen Steel Play Has CBAM Behind It
  • Netflix Fell Nearly 6% After Hours. Options Said 9.6%.

Search

Categories

  • Business
  • Economy
  • Market News
  • Newsletters
  • Top News

You may have missed

b2f7cc31-8932-4738-82ce-a307fd428d38
  • Top News

The KOSPI’s 3.52% Drop Is Now Inside the Bank of Korea

Editor October 22, 2026
229d6af6-172c-47fd-a5ac-fe6670a2b3d3
  • Newsletters

AstraZeneca’s Kidney Readout. The Real Question Is What Options Didn’t Do.

Editor October 22, 2026
121d2608-2202-4aa0-87db-b8015f5eda99
  • Newsletters

5 seconds

Editor October 22, 2026
135e38d2-9ba5-4799-85f1-67ac540fbf1a
  • Business

Lam Research’s Perfect Quarter Wasn’t Enough. That’s the Problem.

Editor October 22, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service/Use Agreement
  • Contact Us
Copyright 2026 © All rights reserved | Options Trading Report | optionstradingreport.com SITE_OK
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}